Gene · 3020
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapid intraoperative amplicon sequencing of CNS tumor markers. | Comput Struct Biotechnol J | 2024 | 39606159 | PubTator, text mining | PubMed |
| Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell tumor of bone. | Hum Cell | 2024 | 39604602 | PubTator, text mining | PubMed |
| Novel Fibroblast Growth Factor Receptor 3-Fatty Acid Synthase Gene Fusion in Recurrent Epithelioid Glioblastoma Linked to Aggressive Clinical Progression. | Curr Oncol | 2024 | 39590169 | PubTator, text mining | PubMed |
| Case report: Polymorphous low-grade neuroepithelial tumor of the young and supratentorial ependymoma diagnosed in an adult male. | Front Neurol | 2024 | 39582680 | PubTator, text mining | PubMed |
| [Pediatric giant cell tumor of bone: a clinicopathological analysis of 35 cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39482050 | PubTator, text mining | PubMed |
| Characterization of the Rat Osteosarcoma Cell Line UMR-106 by Long-Read Technologies Identifies a Large Block of Amplified Genes Associated with Human Disease. | Genes (Basel) | 2024 | 39457378 | PubTator, text mining | PubMed |
| H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications. | Cancers (Basel) | 2024 | 39456545 | PubTator, text mining | PubMed |
| Fulminant leptomeningeal disease diagnosed as comutant H3F3A and FGFR diffuse midline glioma. | Ann Clin Transl Neurol | 2024 | 39440520 | PubTator, text mining | PubMed |
| Meta-Analysis and DIA-MS-Based Proteomic Investigation of COPD Patients and Asymptomatic Smokers in the Indian Population. | J Proteome Res | 2024 | 39436829 | PubTator, text mining | PubMed |
| [Clinicopathological and molecular characteristics of pediatric gliomas: analysis of 111 cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39231745 | PubTator, text mining | PubMed |
| Case report: Giant cell tumor of bone in the mandible of a goat-diagnostics, surgical treatment, and outcome. | Front Vet Sci | 2024 | 39176401 | PubTator, text mining | PubMed |
| Primary spinal cord gliomas: Pathologic features associated with prognosis. | J Neuropathol Exp Neurol | 2024 | 39074166 | PubTator, text mining | PubMed |
| Genomic Insights Into High-Grade Infarct-Associated Bone Sarcomas. | Mod Pathol | 2024 | 39033963 | PubTator, text mining | PubMed |
| An extremely rare case of primary alveolar rhabdomyosarcoma in the central nervous system. | Surg Neurol Int | 2024 | 38974556 | PubTator, text mining | PubMed |
| Proteomics Analysis of Interactions between Drug-Resistant and Drug-Sensitive Cancer Cells: Comparative Studies of Monoculture and Coculture Cell Systems. | J Proteome Res | 2024 | 38907724 | PubTator, text mining | PubMed |
| Screening of reference genes for gene expression study in different tissues from the transcriptome data of the vector leafhopper Psammotettix striatus. | Gene | 2024 | 38878986 | PubTator, text mining | PubMed |
| Two Cases of Cutaneous Sarcomatoid Squamous Cell Carcinoma Resembling Cutaneous Giant Cell Tumor of Soft Tissue. | Am J Dermatopathol | 2024 | 38842396 | PubTator, text mining | PubMed |
| [Clinicopathological characteristics of gangliogliomas with anaplastic morphology]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 38825904 | PubTator, text mining | PubMed |
| H3F3A K27M Mutations Drives a Repressive Transcriptome by Modulating Chromatin Accessibility, Independent of H3K27me3 in Diffuse Midline Glioma. | bioRxiv | 2024 | 38798502 | PubTator, text mining | PubMed |
| Giant Cell Tumor of Soft Tissue: An Updated Review. | J Clin Med | 2024 | 38792412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3020/papers?page=7